A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG.
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.
[Gaucher disease: A review].
Nguyen Y, Stirnemann J, Belmatoug N.
Rev Med Interne. 2019 May;40(5):313-322. doi: 10.1016/j.revmed.2018.11.012. Epub 2019 Jan 11.
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Weinreb NJ, Goker-Alpan O, Kishnani PS, Longo N, Burrow TA, Bernat JA, Gupta P, Henderson N, Pedro H, Prada CE, Vats D, Pathak RR, Wright E, Ficicioglu C.
Mol Genet Metab. 2022 May;136(1):4-21. doi: 10.1016/j.ymgme.2022.03.001. Epub 2022 Mar 9.
Gaucher disease.
Guggenbuhl P, Grosbois B, Chalès G.
Joint Bone Spine. 2008 Mar;75(2):116-24. doi: 10.1016/j.jbspin.2007.06.006. Epub 2007 Aug 31.
Gaucher disease.
Ali MA, Saleh FM, Das K, Latif T.
Mymensingh Med J. 2011 Jul;20(3):490-2.
Neuropathic Gaucher disease.
Pastores GM.
Wien Med Wochenschr. 2010 Dec;160(23-24):605-8. doi: 10.1007/s10354-010-0850-x.
Glucocerebrosidase (Gaucher disease).
Beutler E, Gelbart T.
Hum Mutat. 1996;8(3):207-13. doi: 10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6.
Gaucher disease: unmet treatment needs.
Mehta A.
Acta Paediatr. 2008 Apr;97(457):83-7. doi: 10.1111/j.1651-2227.2008.00653.x.
Gaucher disease.
Beutler E.
Blood Rev. 1988 Mar;2(1):59-70. doi: 10.1016/0268-960x(88)90009-4.
The clinical management of Type 2 Gaucher disease.
Weiss K, Gonzalez A, Lopez G, Pedoeim L, Groden C, Sidransky E.
Mol Genet Metab. 2015 Feb;114(2):110-122. doi: 10.1016/j.ymgme.2014.11.008. Epub 2014 Nov 14.
